Zymeworks Inc. Gains 23.19%

Fri, Apr 29, 2022 at 05:30 PM
Zymeworks Inc. Gains 23.19%

Zymeworks Inc. (ZYME:NYSE) rocketted at $6.11, a gain of 23.2%. On Thu, Apr 28, 2022, ZYME:NYSE touched a New 2-Week Intraday Low of $4.56. The stock appeared on our News Catalysts scanner on Thu, Apr 28, 2022 at 09:08 AM in the 'BIOTECH' category. From Thu, Apr 14, 2022, the stock recorded 44.44% Up Days and 30.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Zymeworks Inc. (ZYME:NYSE)

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.